Testosterone (Transdermal)
Secondary Exposure to Testosterone
- Virilization has been reported in children who were secondarily exposed to testosterone gel [see Warnings and Precautions (5.2) and Adverse Reactions (6.2)].
- Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel [see Dosage and Administration (2.2) and Warnings and Precautions (5.2)].
- Healthcare providers should advise patients to strictly adhere to recommended instructions for use [see Dosage and Administration (2.2), Warnings and Precautions (5.2) and Patient Counseling Information (17)].
FDA and Industry Communications
Approved Risk Evaluation and Mitigation Strategies (REMS)
Testosterone 1%
Testosterone 1.62%
ANDROGEL (Testosterone) 1% Gel
ANDROGEL (Testosterone) 1.62% Gel
AXIRON (Testosterone)) Gel
FORESTA (Testosterone) Gel
TESTIM (testosterone) Gel
VOGELXO (Testosterone) Gel
Patient Counseling Information
Medication Guides
Package Inserts
Additional Information
Updated January 2018